CHRONIC SYSTEMIC RECOMBINANT-ALPHA-2A-INTERFERON (R-ALPHA(2A)-IFN) INHIBITS LYMPHOCYTE GAMMA-IFN PRODUCTION IN MS

被引：0
|
作者：
BONGIOANNI, MR
FERRIO, MF
FERRERO, B
VAI, S
GEUNA, M
DURELLI, L
机构：
来源：
NEUROLOGY | 1993年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A164 / A164
页数：1
相关论文
共 50 条
  • [1] CHRONIC HIGH-DOSE SYSTEMIC RECOMBINANT-ALPHA-2A-INTERFERON (R-ALPHA(2A)-IFN) IN RELAPSING REMITTING (R/R) MS - CLINICAL AND MRI EVALUATION
    CAVALLO, R
    DURELLI, L
    FERRI, R
    FERRIO, MF
    RIVA, A
    BRADAC, GB
    BERGAMASCO, B
    BERGAMINI, L
    [J]. NEUROLOGY, 1993, 43 (04) : A164 - A164
  • [2] INTERFERON (IFN) THERAPY (RECOMBINANT ALPHA-2C IFN OR RECOMBINANT GAMMA-IFN) IN METASTASIZED HYPERNEPHROMAS
    KUZMITS, R
    SCHEITHAUER, W
    LUDWIG, H
    FLENER, R
    [J]. ACTA MEDICA AUSTRIACA, 1985, 12 : 43 - 43
  • [3] Sequential treatment with lymphoblastoid IFN alpha (IFN alpha-Ly) of Ph+ CML patients resistant to recombinant IFN alpha 2a (IFN alpha 2a): Evaluation of hematologic and karyotypic response in the neutralizing IFN alpha 2a antibodies (nIFN alpha 2a Abs) positive and negative patients
    Russo, D
    Candoni, A
    Zuffa, E
    Minisini, R
    Silvestri, F
    Fanin, R
    Lorenzon, A
    Rosti, GA
    Zaja, F
    Tura, S
    Baccarani, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 281 - 281
  • [4] Fate of antibody to interferon (IFN) in chronic hepatitis C patients treated with recombinant IFN alpha 2 and retreated with lymphoblastoid IFN alpha
    Antonelli, G
    Giannelli, G
    Currenti, M
    Simeoni, E
    Milella, M
    Schiraldi, O
    Dianzani, F
    [J]. INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 1995, 4 (04): : 232 - 237
  • [5] INTERFERON (IFN)-TREATMENT (RECOMBINANT IFN-ALPHA-2C OR RECOMBINANT IFN-GAMMA) IN METASTATIC RENAL-CANCER
    KUZMITS, R
    SCHEITHAUER, W
    FLENER, R
    LUDWIG, H
    [J]. BLUT, 1985, 51 (03): : 234 - 234
  • [6] TREATMENT OF CHRONIC DELTA HEPATITIS WITH ALPHA-2 RECOMBINANT INTERFERON (IFN)
    ROSINA, F
    SARACCO, G
    ACTIS, GC
    BRUNETTO, MR
    MARAN, E
    PINTUS, C
    DIANZANI, F
    VERME, G
    RIZZETTO, M
    BONINO, F
    [J]. GASTROENTEROLOGY, 1986, 90 (05) : 1762 - 1762
  • [7] INTERFERON-(IFN-)TREATMENT (RECOMBINANT IFN-ALPHA-2C OR RECOMBINANT IFN-GAMMA) OF METASTASIZED RENAL-CELL CARCINOMA
    KUZMITS, R
    SCHEITHAUER, W
    LUDWIG, H
    FLENER, R
    [J]. ACTA MEDICA AUSTRIACA, 1985, 12 (05) : 129 - 134
  • [8] INTERFERON (IFN)-ALPHA-2 GENOTYPE ANALYSIS OF CHINESE CHRONIC HEPATITIS-B PATIENTS UNDERGOING RECOMBINANT IFN-ALPHA-2A THERAPY
    CROWE, JS
    GEWERT, DR
    BARBER, KA
    LEWIS, AP
    SIMS, MJ
    DAVIES, SL
    SALOM, CL
    WOOD, J
    THOMAS, HC
    THURSZ, M
    LOK, AS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (04): : 875 - 878
  • [9] The influence of Escherichia coli cultivation temperature on interferon alpha 2a expression (IFN-α2a)
    Fernanda dos Santos Arthuso
    Miriam Fussae Suzuki
    Nélio Alessandro de Jesus Oliveira
    João Ezequiel de Oliveira
    Paolo Bartolini
    Carlos Roberto Jorge Soares
    [J]. BMC Proceedings, 8 (Suppl 4)
  • [10] Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis
    Bongioanni, MR
    Durelli, L
    Ferrero, B
    Imperiale, D
    Oggero, A
    Verdun, E
    Aimo, G
    Pagni, R
    Geuna, M
    Bergamasco, B
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 143 (1-2) : 91 - 99
12345